|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-1-14
|
|
pubmed:abstractText |
To determine if adding etanercept (ETN) to methotrexate (MTX) or MTX to ETN for 52 weeks in rheumatoid arthritis (RA) patients with moderate disease activity provides higher efficacy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1468-2060
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
67
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
182-8
|
|
pubmed:meshHeading |
pubmed-meshheading:17728331-Antirheumatic Agents,
pubmed-meshheading:17728331-Arthritis, Rheumatoid,
pubmed-meshheading:17728331-Drug Administration Schedule,
pubmed-meshheading:17728331-Drug Therapy, Combination,
pubmed-meshheading:17728331-Female,
pubmed-meshheading:17728331-Humans,
pubmed-meshheading:17728331-Immunoglobulin G,
pubmed-meshheading:17728331-Male,
pubmed-meshheading:17728331-Methotrexate,
pubmed-meshheading:17728331-Middle Aged,
pubmed-meshheading:17728331-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:17728331-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
|
|
pubmed:affiliation |
Leiden University Medical Center, PO Box 9600, 2300RC Leiden, The Netherlands. d.vanderheijde@kpnplanet.nl
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
